Evaluating intrinsic and non-intrinsic cancer risk factors

S Wu, W Zhu, P Thompson, YA Hannun - Nature communications, 2018 - nature.com
Discriminating the contribution of unmodifiable random intrinsic DNA replication errors ('bad
luck') to cancer development from those of other factors is critical for understanding cancer in …

Racial disparity and triple-negative breast cancer in African-American women: a multifaceted affair between obesity, biology, and socioeconomic determinants

S Siddharth, D Sharma - Cancers, 2018 - mdpi.com
Triple negative breast cancer (TNBC) is a molecularly heterogeneous disease whose
incidence is disproportionately higher in African American (AA) women compared to …

Differences in breast cancer survival by molecular subtypes in the United States

N Howlader, KA Cronin, AW Kurian… - … , Biomarkers & Prevention, 2018 - AACR
Background: Although incidence rates of breast cancer molecular subtypes are well
documented, effects of molecular subtypes on breast cancer–specific survival using the …

Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state

BA Kohler, RL Sherman, N Howlader… - Journal of the …, 2015 - academic.oup.com
Abstract Background: The American Cancer Society (ACS), Centers for Disease Control and
Prevention (CDC), National Cancer Institute (NCI), and North American Association of …

Evaluation of racial/ethnic differences in treatment and mortality among women with triple-negative breast cancer

B Cho, Y Han, M Lian, GA Colditz, JD Weber… - JAMA …, 2021 - jamanetwork.com
Importance To our knowledge, there is no consensus regarding differences in treatment and
mortality between non-Hispanic African American and non-Hispanic White women with triple …

[HTML][HTML] Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early …

A Goldhirsch, EP Winer, AS Coates, RD Gelber… - Annals of oncology, 2013 - Elsevier
Abstract The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel
reviewed and endorsed substantial new evidence on aspects of the local and regional …

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status

N Howlader, SF Altekruse, CI Li… - Journal of the …, 2014 - academic.oup.com
Abstract Background In 2010, Surveillance, Epidemiology, and End Results (SEER)
registries began collecting human epidermal growth factor 2 (HER2) receptor status for …

Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline

HS Rugo, RB Rumble, E Macrae, DL Barton… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To develop recommendations about endocrine therapy for women with hormone
receptor (HR)–positive metastatic breast cancer (MBC). Methods The American Society of …

How many etiological subtypes of breast cancer: two, three, four, or more?

WF Anderson, PS Rosenberg, A Prat… - Journal of the …, 2014 - academic.oup.com
Breast cancer is a heterogeneous disease, divisible into a variable number of clinical
subtypes. A fundamental question is how many etiological classes underlie the clinical …

Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors

ET Warner, RM Tamimi, ME Hughes… - Journal of clinical …, 2015 - ascopubs.org
Purpose To evaluate the relationship between race/ethnicity and breast cancer–specific
survival according to subtype and explore mediating factors. Patients and Methods …